Transchem

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE019B01010
  • NSEID:
  • BSEID: 500422
INR
160.00
-4.45 (-2.71%)
BSENSE

Feb 09

BSE+NSE Vol: 8.34 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 538955,
    "name": "Transchem",
    "stock_name": "Transchem",
    "full_name": "Transchem Ltd",
    "name_url": "stocks-analysis/transchem",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "160.00",
    "chg": -4.45,
    "chgp": "-2.71%",
    "dir": -1,
    "prev_price": "164.45",
    "mcapval": "192.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 500422,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE019B01010",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "8.34 k",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/transchem-538955-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Transchem Ltd Investment Rating Upgraded to Sell on Technical Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-investment-rating-upgraded-to-sell-on-technical-improvements-3827980",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TranschemLtd_mojoScore_3827980.png",
        "date": "2026-02-09 08:03:07",
        "description": "Transchem Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Strong Sell to Sell as of 6 February 2026. This change reflects a nuanced shift in the company’s technical outlook despite ongoing financial challenges, with the MarketsMOJO Mojo Score adjusting to 31.0. Investors are advised to consider the detailed analysis across quality, valuation, financial trends, and technical indicators before making decisions."
      },
      {
        "title": "Are Transchem Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-transchem-ltd-latest-results-good-or-bad-3826811",
        "imagepath": "",
        "date": "2026-02-07 19:17:55",
        "description": "Transchem Ltd's latest financial results for Q2 FY26 reveal significant operational challenges, primarily characterized by a complete absence of net sales, which remained at ₹0.00 crore for two consecutive quarters. This stark situation contrasts sharply with the previous year, where minimal trading activity was recorded. The company reported a net profit of ₹0.68 crore, reflecting a decline of 31.31% quarter-on-quarter, driven largely by its reliance on other income, which accounted for ₹1.68 crore in the latest quarter. This other income represents a substantial 239.36% of profit before tax, underscoring the company's dependence on non-operating sources for its financial performance.\n\nThe operational metrics indicate that Transchem has not generated any meaningful sales since Q1 FY26, and its core business continues to incur losses, with an operating profit before depreciation, interest, and tax (excludin..."
      },
      {
        "title": "Transchem Ltd Q2 FY26: Operations Stalled, Other Income Props Up Profits",
        "link": "https://www.marketsmojo.com/news/result-analysis/transchem-ltd-q2-fy26-operations-stalled-other-income-props-up-profits-3826538",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/Transchem_quaterlyResult_3826538.png",
        "date": "2026-02-07 15:47:00",
        "description": "Transchem Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹204.00 crores, reported net profit of ₹0.68 crores for Q2 FY26, down 31.31% quarter-on-quarter from ₹0.99 crores in Q1 FY26. The company continues to face operational challenges, with zero sales recorded for the second consecutive quarter whilst remaining almost entirely dependent on other income to sustain profitability."
      },
      {
        "title": "When is the next results date for Transchem Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-transchem-ltd-3819098",
        "imagepath": "",
        "date": "2026-02-03 23:16:35",
        "description": "The next results date for Transchem Ltd is scheduled for 07 February 2026...."
      },
      {
        "title": "Transchem Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-downgraded-to-strong-sell-amid-mixed-technicals-and-weak-financials-3815561",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TranschemLtd_mojoScore_3815561.png",
        "date": "2026-02-02 08:05:21",
        "description": "Transchem Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 February 2026. This adjustment reflects a complex interplay of deteriorating financial fundamentals, cautious valuation metrics, and nuanced technical signals, despite the company’s impressive long-term stock returns. Investors are urged to carefully consider these factors amid the evolving market landscape."
      },
      {
        "title": "Transchem Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-is-rated-sell-by-marketsmojo-3809104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TranschemLtd_mojoScore_3809104.png",
        "date": "2026-01-29 10:11:07",
        "description": "Transchem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 January 2026, providing investors with the latest insights into the company's performance and outlook."
      },
      {
        "title": "Transchem Ltd Falls 5.88%: Key Factors Behind This Week’s Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/transchem-ltd-falls-588-key-factors-behind-this-weeks-decline-3788490",
        "imagepath": "",
        "date": "2026-01-10 17:01:39",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 5:</strong> New 52-week and all-time high at Rs.194.25</p>\n                    <p><strong>Jan 6:</strong> Sharp decline on low volume</p>\n                    <p><strong>Jan 7-9:</strong> Continued selling pressure with daily losses near 2%</p>\n                    <p><strong>Jan 9:</strong> Week closes at Rs.179.25, down 5.88%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.190.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.179.25</div><div class=\"stat-change negative\">-5.88..."
      },
      {
        "title": "Transchem Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/transchem-ltd-is-rated-sell-by-marketsmojo-3784321",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TranschemLtd_mojoScore_3784321.png",
        "date": "2026-01-07 10:10:55",
        "description": "Transchem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 07 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Transchem Ltd Hits New 52-Week High at Rs.194.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/transchem-ltd-hits-new-52-week-high-at-rs19425-3781945",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TranschemLtd_priceRelatedfactors_3781945.png",
        "date": "2026-01-05 10:46:22",
        "description": "Transchem Ltd has surged to a fresh 52-week and all-time high of Rs.194.25, reflecting a robust rally that has propelled the stock to new heights within the Pharmaceuticals & Biotechnology sector. This milestone underscores the stock’s strong momentum amid a broader market environment showing signs of recovery."
      }
    ],
    "total": 167,
    "sid": "538955",
    "stock_news_url": "https://www.marketsmojo.com/news/transchem-538955"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for The Meeting Held On February 07 2026 Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "07-Feb-2026",
      "details": "Please refer the attached intimation.",
      "source": "BSE"
    },
    {
      "caption": "Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 Along With Limited Review Report.",
      "datetime": "07-Feb-2026",
      "details": "Please refer the attached intimation.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for For Approval Of Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.",
      "datetime": "02-Feb-2026",
      "details": "Transchem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 inter alia to consider and approve Un-Audited Financial Results of the Company for the Quarter and Nine Months ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Outcome for The Meeting Held On February 07 2026 Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.

07-Feb-2026 | Source : BSE

Please refer the attached intimation.

Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 Along With Limited Review Report.

07-Feb-2026 | Source : BSE

Please refer the attached intimation.

Board Meeting Intimation for For Approval Of Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.

02-Feb-2026 | Source : BSE

Transchem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 inter alia to consider and approve Un-Audited Financial Results of the Company for the Quarter and Nine Months ended December 31 2025.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available